![](https://www.itaa.org/wp-content/uploads/2020/02/HIV_drug-patent-540x304.jpeg)
Gilead Sciences Loses Patent Dispute for HIV Drug to Government Agency
In less than a month, the biopharmaceutical company Gilead Sciences, Inc., has lost two rulings related to its patent dispute with the United States Department of Health & Human Services…